Long-term protective effect of post-exposure Havrix™ administration during viral hepatitis Type A outbreaks

European Journal of Epidemiology

Volumn 21, Issue 12, 2006, Pages 893-899

  Kohl, I ^a   Nemecek V ^b   Summerova M ^b   Chlibek R ^c   Nad'ova K ^d   Minarikova O ^d  

^a GLAXOSMITHKLINE   (United Kingdom)

^b NATIONAL INSTITUTE OF PUBLIC HEALTH   (Czech Republic)

^c DEPARTMENT OF TOXICOLOGY   (Czech Republic)

^d State Institute of Public Health Slovakia   (Slovakia)

Author keywords

Hepatitis A infection; Hepatitis A vaccine; Human immunoglobulin; Outbreak control

Indexed keywords

HEPATITIS A ANTIBODY; HEPATITIS A VACCINE; HUMAN IMMUNOGLOBULIN; NORGA IMMUNA; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; CHILD; CONTROLLED STUDY; DRUG EFFECT; EPIDEMIC; HEPATITIS A; HUMAN; MAJOR CLINICAL STUDY; NEWBORN; SINGLE DRUG DOSE; SLOVAKIA; STATISTICAL SIGNIFICANCE; VACCINATION;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; DISEASE OUTBREAKS; FEMALE; HEPATITIS A; HEPATITIS A VACCINES; HUMANS; IMMUNOGLOBULINS; INFANT; INFANT, NEWBORN; MALE; SLOVAKIA; VACCINES, INACTIVATED;

EID: 33846679351     PISSN: 03932990     EISSN: 15737284     Source Type: Journal    
DOI: 10.1007/s10654-006-9081-2     Document Type: Article

References (22)

1. Advisory Committee on Immunization Practices (ACIP); Fiore AE, Wasley A, Bell BP. Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2006 May 19; 55(RR-7): 1-23.
2. Wheeler C, Vogt TM, Armstrong GL, et al. An outbreak of hepatitis A associated with green onions.. N Engl J Med 2005; 353(9): 890-7.
3. Tregnaghi M, Ussher J, Ruttimann R, Jalil M, Tanaka J, Safary A. Effect of the use of vaccine during an epidemic of Hepatitis A in a town in Argentina. Bol Venez Infectol 1997; 7 (Suppl.1).
4. Trmal J, Jílková E, Zenková E, Ondřej J. Vaccination of children against viral hepatitis A (HAV). Čs Pediat 1996; 51(11): 669-673.
5. Werzberger A, Mensch B, Kuter B, et al. A controlled trial of formalin-inactivated hepatitis A vacccine in healthy children. N Engl J Med 1992; 327: 453-457.
6. Kohl I, Príkazský V, Oleár V, van Hoecke C, André FE, Safary A. Protective effect of post-exposure Havrix™ administration under conditions of viral hepatitis A occurrence FIMSA. Australia: Adelaide, 1996, 100 pp.
7. Specialized State Health Institute. Analysis of the epidemiological situation in Slovakia in 1993. Banská Bystrica, Slovak Republic 1994: 6-8.
8. Specialized State Health Institute. Analysis of the epidemiological situation in Slovakia in 1995. Banská Bystrica, Slovak Republic, 1996: 16-17.
9. State Health Institute. Analysis of the epidemiological situation in Slovakia in 2001. Banská Bystrica, Slovak Republic, 2002: 24.
10. State Health Institute. Analysis of the epidemiological situation in Slovakia in 2000. Banská Bystrica, Slovak Republic, 2001: 23-26.
11. Behrens RH, Doherty JF. Severe hepatitis A despite passive immunization. Lancet 1993; 341: 972.
12. Príkazský V, Oleár V, Černoch A, Safary A, André FE. Interruption of an outbreak of hepatitis A in two villages by vaccination. J Med Virol 1994; 44: 457-459.
13. McMahon BJ, Beller M, Williams J, Schloss M, Tanttila H, Bulkow L. A program to control an outbreak of hepatitis A in Alaska by using an inactivated hepatitis A vaccine. Arch Pediatr Adolesc Med 1996; 150: 733-739.
14. Irwin DJ, Millership S. Control of a community hepatitis outbreak using hepatitis A vaccine. Commun Dis Public Health 1999; 2(3): 184-187.
15. Poovorawan Y, Tieamboonlers A, Chumdermpadetsuk S, Gluck R, Cryz SJ Jr. Control of a hepatitis A outbreak by active immunization of high-risk susceptible subjects.. J Infect Dis 1994; 169: 229-230.
16. Taliani G, Gaeta GB. Hepatitis A: Post-exposure prophylaxis. Vaccine 2003; 21(19-20): 2234-7.
17. Sagliocca L, Amoroso P, Stroffolini T, et al. Efficacy of hepatitis A vaccine in prevention of secondary hepatitis A infection: A randomised trial. Lancet 1999; 353(9159): 1136-9.
18. Hauri AM, Fischer E, Fitzenberger J, Uphoff H, Koenig C. Active immunisation during an outbreak of hepatitis A in a German day-care centre. Vaccine 2006; 24(29-30): 5684-9.
19. Winokur PL, Stapleton JT. Immunoglobulin prophylaxis for hepatitis A. Clin Infect Dis 1992; 14(2): 580-6.
20. Irwin DJ, Millership S. Antibody responses to Hepatitis A vaccine in healthy adults. Commun Dis Public Health 2001; 4(2): 139-40.
21. Khuroo MS. Viral hepatitis in international travellers: Risks and prevention. Int J Antimicrob Agents 2003; 21(2): 143-52.
22. van Herck K, van Damme P. Prevention of hepatitis A by Havrix: A review. Expert Rev Vaccines 2005; 4(4): 459-71.